• Something wrong with this record ?

Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat

M. Kunes, J. Kvetina, J. Bures

. 2009 ; 30 Suppl 1 () : 96-100.

Language English Country Sweden

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVES: The therapy with non-steroidal anti-inflammatory drugs (e.g. indomethacin) is often accompanied with adverse effects in gastrointestinal tract. Aim of this experimental study was to define the time range of the creation of indomethacin-induced gastrointestinal lesions in rat (for prospective study of potential probiotic therapy). The paper follows our previous experiments where the different gastrointestinal lesions were described in the pig (Kvetina et al. 2008) METHODS: Indomethacin (25mg/kg) was administered orally by a single application to rat (Wistar Han II, 200-250g). Six, 24, 48 and 72 hours after the indomethacin administration all parts of the gastrointestinal tract of six rats in each time interval were macroscopically and histologically examined. RESULTS AND CONCLUSION: The gradual development of lesions was observed 6 hours in stomach and 24-72 hours in the intestine after the indomethacin administration. Not only the gradual development of pathophysiological alterations was observed but also the reparative phase (in stomach). 24 hours seem to be advisable time suitable for the evaluation of the probiotics effect as a potential therapy) on the indomethacin-induced gastrointestinal lesions in rats. Sensitivity of the gastrointestinal tract to the pathological lesions development seems to be higher in rats in comparison to findings described in our previous experiments in pig (Kvetina et al. 2008). This adverts to interspecies differences in the manifestation and in the dynamics of the development of gastrointestinal lesions.

000      
00000naa a2200000 a 4500
001      
bmc12025388
003      
CZ-PrNML
005      
20130128193643.0
007      
ta
008      
120816s2009 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)20027152
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Kuneš, Martin $7 xx0081968 $u Institute of Experimental Biopharmaceutics, Czech Academy of Sciences, Czech Republic. kunes@uebf.cas.cz
245    10
$a Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat / $c M. Kunes, J. Kvetina, J. Bures
520    9_
$a OBJECTIVES: The therapy with non-steroidal anti-inflammatory drugs (e.g. indomethacin) is often accompanied with adverse effects in gastrointestinal tract. Aim of this experimental study was to define the time range of the creation of indomethacin-induced gastrointestinal lesions in rat (for prospective study of potential probiotic therapy). The paper follows our previous experiments where the different gastrointestinal lesions were described in the pig (Kvetina et al. 2008) METHODS: Indomethacin (25mg/kg) was administered orally by a single application to rat (Wistar Han II, 200-250g). Six, 24, 48 and 72 hours after the indomethacin administration all parts of the gastrointestinal tract of six rats in each time interval were macroscopically and histologically examined. RESULTS AND CONCLUSION: The gradual development of lesions was observed 6 hours in stomach and 24-72 hours in the intestine after the indomethacin administration. Not only the gradual development of pathophysiological alterations was observed but also the reparative phase (in stomach). 24 hours seem to be advisable time suitable for the evaluation of the probiotics effect as a potential therapy) on the indomethacin-induced gastrointestinal lesions in rats. Sensitivity of the gastrointestinal tract to the pathological lesions development seems to be higher in rats in comparison to findings described in our previous experiments in pig (Kvetina et al. 2008). This adverts to interspecies differences in the manifestation and in the dynamics of the development of gastrointestinal lesions.
650    _2
$a aplikace orální $7 D000284
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika nesteroidní $x aplikace a dávkování $x toxicita $7 D000894
650    _2
$a gastrointestinální nemoci $x chemicky indukované $x patologie $7 D005767
650    _2
$a indomethacin $x aplikace a dávkování $x toxicita $7 D007213
650    _2
$a střeva $x účinky léků $x patologie $7 D007422
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prospektivní studie $7 D011446
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a žaludek $x účinky léků $x patologie $7 D013270
650    _2
$a časové faktory $7 D013997
650    _2
$a testy toxicity $7 D018675
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Květina, Jaroslav, $d 1930- $7 jk01071205
700    1_
$a Bureš, Jan, $d 1954- $7 nlk19990073060
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 96-100
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20027152 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120816 $b ABA008
991    __
$a 20130128193829 $b ABA008
999    __
$a ok $b bmc $g 947430 $s 782734
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 30 Suppl 1 $d 96-100 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20120816/10/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...